Ho M N, Delgado C H, Owens G A, Steller M A
Section of Gynecologic Oncology, National Cancer Institute, Bethesda, Maryland 20892-1502, USA.
Fertil Steril. 1997 May;67(5):870-6. doi: 10.1016/s0015-0282(97)81399-4.
To examine the involvement of insulin-like growth factors (IGFs) in growth regulation of an ovarian cancer cell line and to investigate whether the GnRH agonist tryptorelin might influence a potential autocrine or paracrine loop involving IGFs.
In vitro, prospective, randomized controlled study.
In vitro experiments at the Section of Gynecologic Oncology, Surgery Branch, National Cancer Institute.
PATIENT(S): None. Human ovarian adenocarcinoma cell line IGROV-1.
INTERVENTION(S): The proliferative effect of tryptorelin on IGROV-1 cells was analyzed by using the MTT (93-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide) colorimetric assay. The ribonuclease protection assay was used to investigate whether an autocrine pathway involving IGF-I or IGF-II might participate in the growth of these cells. The expression of GnRH receptor was assessed by the 125I-GnRH binding assay.
MAIN OUTCOME MEASURE(S): Changes in cell growth and expression of IGF-I and IGF-II messenger RNA (mRNA).
RESULT(S): Tryptorelin exhibited a bimodal, dose- and time-dependent effect on IGROV-1 cells when compared with untreated control cells: Cellular proliferation was enhanced during the first 24 hours of exposure, but longer incubations resulted in growth inhibition. The mitogenic effect of tryptorelin was inhibited when cells were co-incubated with either IGF binding protein-5 (IGFBP-5) or anti-IGF-II antibody, which can both bind to IGF-II and neutralize it. Insulin-like growth factor-I mRNA was not detected in IGROV-1 cells. However, IGF-II transcripts were detected after incubation with tryptorelin for 12 hours, but thereafter, no mRNA was observed, even after prolonged exposure. Binding analysis revealed a specific, high-affinity GnRH binding site.
CONCLUSION(S): These data suggest that tryptorelin exerts a bimodal growth effect on ovarian cancer cells by a mechanism involving the autocrine production of IGF-II. The effect of tryptorelin on IGF-II gene transcription in these ovarian cancer cells appears to mirror the desensitizing effects of prolonged GnRH exposure on pituitary gonadotropin production.
研究胰岛素样生长因子(IGFs)在卵巢癌细胞系生长调节中的作用,并探讨促性腺激素释放激素(GnRH)激动剂曲普瑞林是否可能影响涉及IGFs的潜在自分泌或旁分泌环路。
体外前瞻性随机对照研究。
国立癌症研究所外科分部妇科肿瘤学组的体外实验。
无。人卵巢腺癌细胞系IGROV-1。
采用MTT(噻唑蓝)比色法分析曲普瑞林对IGROV-1细胞的增殖作用。用核糖核酸酶保护试验研究涉及IGF-I或IGF-II的自分泌途径是否可能参与这些细胞的生长。通过¹²⁵I-GnRH结合试验评估GnRH受体的表达。
细胞生长以及IGF-I和IGF-II信使核糖核酸(mRNA)表达的变化。
与未处理的对照细胞相比,曲普瑞林对IGROV-1细胞表现出双峰、剂量和时间依赖性效应:在暴露的最初24小时内细胞增殖增强,但孵育时间延长则导致生长抑制。当细胞与既能结合IGF-II又能中和它的IGF结合蛋白-5(IGFBP-5)或抗IGF-II抗体共同孵育时,曲普瑞林的促有丝分裂作用受到抑制。在IGROV-1细胞中未检测到胰岛素样生长因子-I mRNA。然而,与曲普瑞林孵育12小时后检测到IGF-II转录本,但此后,即使长时间暴露也未观察到mRNA。结合分析显示存在一个特异性、高亲和力的GnRH结合位点。
这些数据表明,曲普瑞林通过涉及IGF-II自分泌产生的机制对卵巢癌细胞发挥双峰生长效应。曲普瑞林对这些卵巢癌细胞中IGF-II基因转录的影响似乎反映了GnRH长期暴露对垂体促性腺激素产生的脱敏作用。